Antimicrobial evaluation of quinones and heterocyclic compounds against mycobacterium marinum, M. kansasii and M. abscessus

Latin American Journal of Pharmacy

Volumn 31, Issue 4, 2012, Pages 507-513

  Cantos, Jéssica B ^a   Coelho, Tatiane S ^a   Carneiro, Paula F ^b   de Moura, Kelly C G ^b   Pinto, Maria do C F R ^b   da Silva Júnior, Eufrânio N ^c   da Silva, Pedro E A ^a  

^a UFRG   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antimycobacterial activity; MNT; Quinones; REMA; Susceptibility

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; ANTIINFECTIVE AGENT; BETA LAPACHONE; CLARITHROMYCIN; HETEROCYCLIC COMPOUND; ISONIAZID; LAPACHOL; NAPHTHOIMIDAZOLE DERIVATIVE; NAPHTHOXAZOLE DERIVATIVE; NOR BETA LAPACHONE; NOR LAPACHOL; PHENAZINE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; NONHUMAN;

EID: 84863881203     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Falkinham, J.O. (2002) Clin. Chest. Med. 23: 529-51.
2. Griffith, D.E., T. Aksamit, B.A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, et al. (2007) Am. J. Respir. Crit. Care Med 175: 367-416.
3. Tortoli, E. (2003) Clin. Microbiol. 16: 319-54.
4. Falkinham, J.O. (1996) Clin. Microbiol. 9: 177-215.
5. Wayne, L.G. & H.A. Sramek (1992) Clin. Microbiol. 5: 1-25.
6. Waard, J. H. & J. Robledo (2007) Tuberculosis 12: 401-24.
7. Ang, P., N. Rattana-Apiromikaij & C.L. Goh (2000) In. J. Dermatol. 39: 343-7.
8. Ho, P. L., P. Ho, B.K.K. Fung, W.Y. Ip & S.S.Y Wong (2001) Scand. J. Infect. Dis. 33: 232-3.
9. Dailloux, M., C. Laurain, M. Weber & P.H. Hartemann (1999) Water Res. 33: 2219-28.
10. th Ed (P. Murray, E. Baron, M. Pfalter, F. Tenover & R. Yolken, eds). Washington: American Society for Microbiology, pp. 399-473.
11. Katoch, V.M. (2004) Indian J. Med. Res. 120: 290-304.
12. Brown-Elliott, B.A. & R.J. Wallace Jr (2002) Clin. Microbiol Rev. 15: 716-46.
13. Hayes, D.J.R. (2005) South Med. J. 98: 657-61.
14. Freitas, D., L. Alvarenga, J. Sampaio, M. Mannis, E. Sato, L. Souza et al. (2003) Ophthalmology 110: 276-85.
15. Alfa, M.J., J.J. Sisler & G.K. Harding (1995) Can. Med. Assoc. J. 153: 1293-6.
16. Murillo, J., J. Torres, L. Bofill, A. Ríos-Fabra, E. Irausquin, R. Istúriz, et al. (2000) Arch. Dermatol. 136: 1347-52.
17. Toy, B.R. & P.J. Frank (2003) Dermatol. Surg. 29: 971-3.
18. Ryu, H.J., W.J. Kim, C.H. Oh & H.S. Song (2005) Int. J. Dermatol. 44: 846-50.
19. Schulze-Robbecke, R. (1993) Immun. Infekt German 21: 126-31.
20. Brown-Elliott, B.A., R.J. Wallace Jr (2001) J. Clin.Microbiol. 39: 2745-6.
21. Nagai J. & M. Takano (2004) Drug Metab. Pharmacokinet 19: 159-70.
22. Falkenberg, M.B. (2004) Quinonas. In: Farmacognosia: da planta ao medicamento (C.M.O. Simões, E.P. Schenkel, G. Gosmann, J.C.P. Mello, L. Mentz & P.R. Petrovick, eds), pp. 657-83.
23. Silva, M.N., V.F. Ferreira & M.C.B.V. Souza (2003) Quim. Nova 26: 407-16.
24. Da Silva Júnior, E.N., R.F.S. Menna-Barreto, M.C.F.R. Pinto, R.S.F. Silva, D.V. Teixeira, M.C.B.V. De Souza et al. (2008) Eur. J. Med. Chem. 43: 1774-80.
25. Da Silva Júnior, E.N., C.F. De Deust, B.C. Cavalcanti, C. Pessoa, L.V. Costa-Lotufo, R.C. Montenegro et al. (2010) J. Med. Chem. 53: 504-8.
26. Hussain, H., K Krohn, V.U. Ahmad, G.A. Miana, I.R. Green (2007) Arkivoc. 2: 145-71.
27. Ferreira, V.F. (1996) Química Nova na Escola 4: 35-6.
28. Etlinger, M. (1950) J. Am. Chem. Soc. 72: 3090-5.
29. Fieser, L.F. & M. Fieser (1948) J. Am. Chem. Soc. 7: 3215-22.
30. De Moura, K.C.G.; F.S. Emery, C.N. Pinto, M.C.F.R. Pinto, A.P. Dantas, K. Salomão et al. (2001) J. Braz. Chem. Soc. 3: 325-38.
31. Ferreira, V.F., L.C. Coutada, M.C.F.R. Pinto & A.V. Pinto (1982) Synth. Commun. 12: 195-9.
32. De Moura, K.C.G., K. Salomão, R.F.S.M. Barreto, F.S. Emery, M.C.F.R. Pinto, A.V. Pinto et al. (2004) Eur. J. Med. Chem. 39: 639-45.
33. Silva, R.S.F., E.M Costa, U.L.T Trindade, D.V Teixeira, M.C.F.R Pinto, G.L Santos et al. (2006) Eur. J. Med. Chem. 41: 526-30.
34. Hooker, S. C. (1936) J. Am. Chem. Soc. 58: 1190-7.
35. Benedetti-Doctorovic, V., M. Escola & G. Burton (1998) Magnetic Res. Chem. 36: 529-32.
36. Carneiro, P. F.; M.C.F.R. Pinto, T.S. Coelho, B.C. Cavalcanti, C. Pessoa, C.A. De Simone et al. (2011) Eur. J. Med. Chem. 46: 4521-9.
37. Da Silva Júnior, E.N., M.C.F.R. Pinto, K.C.G. De Moura, C.A. De Simone, C.J. Nascimento, C.K.Z. Andrade et al. (2009) Tetrahedron 50: 1575-7.
38. Palomino, J.C., A. Martin, M. Camacho, H. Guerra, J. Swings & F. Portaels (2002) Antimicrob. Agents Chemother. 46: 2720-2.
39. Guiraud, P., R. Steiman, G.M. Campos-Takaki, F. Seigle-Murandi & M.S. Buochberg (1994) Planta Med. 60: 373-4.
40. Lima, O.G., I.L. Dì Albuquerque, A.P. Borba & J.F Mello (1962) Rev. do Instit. de Antibióticos 6: 23-34.
41. Santos, M.G.M., M.H.C. Lagrota, M.D. Wigg, M.M.F. Miranda, A.V. Pinto & M.C.F.R. Pinto (1992) Rev. Bras. Farm. 73: 78-80.
42. Menna-Barreto, R. F. S., J.R. Corrêa, A.V. Pinto, M.J. Soares & S.L Castro (1997) Parasitol. Res. 101: 895-905.
43. American Thoracic Society (1997) Am. J. Respir. Crit. Care Med. 156: S1-S25.
44. Wagner, D. & L.S Young (2004) Infection 32: 257-70.
45. Dubin, M., S.H. Fernandez-Villamil & A.O.M Stoppani (2001) Medicina 61: 343-50.
46. Laurensen, J.B. & J. Nielsen (2004) Chem. Rev. 104: 1663-85.
47. Matlola, N.M., H.C. Steel & R. Anderson (2001) J Antimicrob. Chemother. 47: 199-202.
48. Zhang, Y. & L. Amzel (2002) Curr. Drug Targets 3: 131-54.
49. Coelho, T.S., R.S. Silva, A.V. Pinto, M.C. Pinto, C.J. Scaini, K.C.G. De Moura, et al. (2010) Tuberculosis 90: 293-97.